Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07901179
PHASE2

A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder

Sponsor: Alkermes, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the efficacy, safety and tolerability of ALKS 7290 following oral administration in adult participants with Major Depressive Disorder.

Official title: A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2026-10

Completion Date

2028-01

Last Updated

2026-10-28

Healthy Volunteers

No

Interventions

DRUG

ALKS 7290 Dose

Daily oral ALKS 7290 with antidepressant therapy

DRUG

Placebo

Daily oral placebo with antidepressant therapy

Locations (1)

Alkermes Investigator Site

Jacksonville, Florida, United States